Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine

Behavioural Pharmacology

Volumn 14, Issue 3, 2003, Pages 229-235

  De Vry, J ^a   Jentzsch, K R ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Dizocilpine; Drug discrimination; Ifenprodil; Operant behavior; Phencyclidine; Rat; Ro 25 6981

Indexed keywords

DIZOCILPINE; DRUG VEHICLE; IFENPRODIL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; RECEPTOR SUBUNIT; RO 256981;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG DISCRIMINATION; DRUG EFFECT; DRUG POTENCY; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; RAT;

EID: 0037672691     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200305000-00007     Document Type: Article

References (33)

1. Auberson YP, Allgeier H, Bischoff S, Lingenhoehl K, Moretti R, Schmutz M (2002). 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg Med Chem Lett 12:107-110.
2. Avenet P, Léonardon J, Besner F, Graham D, Depoortere H, Scatton B (1997). Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1/NR2A and NR1/NR2B receptors expressed in Xenopus oocytes. Neurosci Lett 223:133-136.
3. Backonja M, Arenst G, Gombar KA, Check B, Zimmerman M (1994). Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 56:51-57.
4. Balster RL, Willetts J (1988.) Receptor mediation of the discriminative stimulus properties of phencyclidine and sigma-opioid agonists. In: Colpaert FC, Balster RL (editors): Transduction Mechanisms of Drug Stimuli. Berlin: Springer-Verlag; pp. 122-135.
5. Balster RL, Nicholson KL, Sanger DJ (1994). Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend 35:211-216.
6. Beardsley PM, Hayes BA, Balster RL (1990). The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J Pharmacol Exp Ther 252:953-959.
7. Boyce S, Rupniak NMJ (2002.) Behavioural studies on the potential of NMDA receptor antagonists as analgesics. In: Sirinathsinghji DJS, Hill RG (editors): NMDA Antagonists as Potential Analgesic Drugs. Basel: Birkhäuser Verlag; pp. 147-164.
8. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, et al. (1999). Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38:611-623.
9. Chaperon F (2002). Discriminative properties of various NMDA receptor antagonists in PCP-trained rats. Eur Neuropsychopharmacol 12:S410.
10. 1A receptor agonist BAY x 3702 in the rat. Eur J Pharmacol 357:1-8.
11. De Vry J, Traber J (1989). Discriminative stimulus properties of the noncompetitive NMDA antagonist MK-801 in the rat. Soc Neurosci Abstr 15:463.8.
12. De Vry J, Horváth E, Schreiber R (2001). Neuroprotective and behavioral effects of the selective metabotropic glutamate receptor mGluR1 antagonist BAY 36-7620. Eur J Pharmacol 428:203-214.
13. 1/2 receptor agonists in a limited-access operant food intake paradigm in the rat. Eur Neuropsychopharmacol (in press).
14. Eide K, Stubhaug H, Oye I, Breivik H (1995). Continuous subcutaneous administration of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia. Pain 61:221-228.
15. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS (1995). NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 64:283-291.
16. France CP, Woods JH, Ornstein P (1989). The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative effects. Eur J Pharmacol 159:133-139.
17. Geter-Douglass B, Witkin JM (1997). Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. Psychopharmacology 133:43-50.
18. Herling S, Coale EH Jr, Hein DW, Winger J, Woods JH (1981). Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon. Psychopharmacology 73:286-291.
19. Jackson A, Sanger DJ (1988). The discriminative stimulus and aversive properties of phencyclidine (PCP) and N-methyl-D-aspartate (NMDA) antagonists. Psychopharmacology 96:S27.
20. Järbe TUC, Johansson JO, Henriksson BG (1975). Drug discrimination in rats: The effects of phencyclidine and ditran. Psychopharmacologia 42:33-39.
21. Koek W (1999). N-methyl-D-aspartate antagonists and drug discrimination. Pharmacol Biochem Behav 64:275-281.
22. Koek W, Woods JH, Winger GD (1988). MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission produces, phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969-974.
23. Koek W, Woods JH, Colpaert FC (1990). N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. J Pharmacol Exp Ther 253:1017-1025.
24. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
25. 3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J Neurochem 70:2147-2155.
26. Narita M, Yoshizawa K, Nomura M, Aoki K, Suzuki T (2001). Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine. Eur J Pharmacol 423:41-46.
27. Sanger DJ, Zivkovic B (1989). The discriminative stimulus effects MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists. J Pharmacol 3:198-204.
28. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD (1989). The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167:127-135.
29. Trube G, Ehrhard P, Malherbe P, Huber G (1996). The selectivity of Re 25-6981 for NMDA receptor subtypes expressed in Xenopus oocytes. Soc Neurosci Abstr 22:693.4.
30. Williams K (1993). Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851-859.
31. Winger G, Hursh SR, Casey KL, Woods JH (2002). Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. J Pharmacol Exp Ther 301:690-697.
32. Witkin JM, Steele TD, Sharpe LG (1997). Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine from saline. J Pharmacol Exp Ther 280:46-52.
33. Yamakura T, Shimoji K (1999). Subunit- and site-specific pharmacology of the NMDA channel. Prog Neurobiol 59:279-298.